Tin tức & Cập nhật
Lọc theo Chuyên ngành:
GLP-1 RAs help lower serum uric acid concentration
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a drug class mainly used for the management of type 2 diabetes, significantly reduces serum uric acid (SUA) concentration, a recent study has shown.
GLP-1 RAs help lower serum uric acid concentration
03 Aug 2022
Low-intensity shock wave safe, effective on moderate erectile dysfunction
Men with moderate erectile dysfunction (ED) may benefit from having 12 sessions of low-intensity shock wave therapy (SWT) twice weekly for 6 weeks, with a treatment protocol of 5,000 impulses, 0.0096 mJ/mm2 energy flux density, and 5-Hz frequency, suggests a study.
Low-intensity shock wave safe, effective on moderate erectile dysfunction
02 Aug 2022
Men with multiple sclerosis at risk of erectile dysfunction
Adult men with multiple sclerosis (MS) are more likely to develop erectile dysfunction (ED), indicating that MS is a potential predictor for ED occurrence, suggest the results of a meta-analysis.
Men with multiple sclerosis at risk of erectile dysfunction
01 Aug 2022
Men with untreated hypogonadism at risk of long-term morbidity, death
Untreated hypogonadism in men appears to elevate the risk of morbidity in the long term and early mortality based on time-related measures of risk only, according to a study.
Men with untreated hypogonadism at risk of long-term morbidity, death
31 Jul 2022
Which drugs raise risk of urinary tract infections?
Some medications may directly cause the occurrence of urinary tract infections (UTIs), and a recent study presented at the 37th Annual European Association of Urology Congress (EAU 2022) has identified six drugs that appear to contribute to “significant reporting levels” for infections.
Which drugs raise risk of urinary tract infections?
29 Jul 2022
SOUNDS: Real-world use affirms efficacy, safety of sacral neuromodulator device for OAB
Delivering electric stimulation to the sacral nerves using an implantable device appears to be safe and effective in the treatment of overactive bladder (OAB) in a real-world setting, according to the France-based SOUNDS study presented at the 37th Annual European Association of Urology Congress (EAU 2022).
